The DOJ had been investigating the off-label use of Infuse. Physicians are able to use products off label, but companies cannot promote off-label use.
More Articles on Orthopedic Devices:
Future of Orthopedic Instrumentation Industry Examined in New Report
20 Orthopedic Device Company Q1 Financial Report Updates
Mazor Revenue Up in Q1 After 3 Robotic Spine System Sales
a
Department of Justice Ends 4-Year Investigation of Infuse Featured
Written by Laura Miller | May 18, 2012
The U.S. Department of Justice announced it would end its four year investigation related to off-label use of Medtronic's Infuse for spinal fusions.
Tagged under
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.